Exact Mass: 480.1817792
Exact Mass Matches: 480.1817792
Found 174 metabolites which its exact mass value is equals to given mass value 480.1817792
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5alpha-Pregnan-3beta,20alpha-diol disulfate
5alpha-Pregnan-3beta,20alpha-diol disulfate, also known as 5α-pregnan-3β,20α-ylene sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20alpha-diol disulfate is an extremely strong acidic compound (based on its pKa). 5alpha-Pregnan-3beta,20alpha-diol disulfate can be found in feces. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5alpha-Pregnan-3beta,20beta-diol disulfate
5alpha-Pregnan-3beta,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
5alpha-Pregnan-3alpha,20beta-diol disulfate
5alpha-Pregnan-3alpha,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3alpha,20beta-diol disulfate is possibly neutral. 5alpha-Pregnan-3alpha,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
C18H32N4O9S (480.18899020000003)
(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is an acylcarnitine. More specifically, it is an (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
[10,13-Dimethyl-17-(1-sulfooxyethyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
beclomethasone propionate
C25H33ClO7 (480.19146980000005)
trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran
(4S,7S,12Br)-7-[[(2R)-2-acetylsulfanyl-3-phenylpropanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid
C26H28N2O5S (480.17188380000005)
(aS)-(5R,7R)-5,6,7,8-tetrahydro-13,14-dimethoxy-7-methyl-6-methylene-1,3-benzodioxolo[5,6:3,4]cycloocta[1,2-f][1,3]benzodioxol-5-yl (2Z)-2-methylbut-enoate|schisandrene A
2-Hydroxy-5-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-4,6-dimethylbenzoic acid 3-hydroxy-2,4,5-trimethylphenyl ester
4-[[4-hydroxy-3-[2-(4-hydroxyphenyl)ethynyl][1,1-biphenyl]-2-yl](4-methoxyphenyl)methylene]-2,5-cyclohexadien-1-one|selaginellin N
Phe Asp Ala Glu
C21H28N4O9 (480.18561980000004)
[3-(13-methyltetradecyl)-5-sulfooxyphenyl] hydrogen sulfate
Ala Asp Glu Phe
C21H28N4O9 (480.18561980000004)
Ala Asp Phe Glu
C21H28N4O9 (480.18561980000004)
Ala Glu Asp Phe
C21H28N4O9 (480.18561980000004)
Ala Glu Phe Asp
C21H28N4O9 (480.18561980000004)
Ala Phe Asp Glu
C21H28N4O9 (480.18561980000004)
Ala Phe Glu Asp
C21H28N4O9 (480.18561980000004)
Cys Cys Lys Gln
Cys Cys Gln Lys
Cys Lys Cys Gln
Cys Lys Gln Cys
Cys Gln Cys Lys
Cys Gln Lys Cys
Asp Ala Glu Phe
C21H28N4O9 (480.18561980000004)
Asp Ala Phe Glu
C21H28N4O9 (480.18561980000004)
Asp Glu Ala Phe
C21H28N4O9 (480.18561980000004)
Asp Glu Phe Ala
C21H28N4O9 (480.18561980000004)
Asp Phe Ala Glu
C21H28N4O9 (480.18561980000004)
Asp Phe Glu Ala
C21H28N4O9 (480.18561980000004)
Asp Pro Ser Tyr
C21H28N4O9 (480.18561980000004)
Asp Pro Tyr Ser
C21H28N4O9 (480.18561980000004)
Asp Ser Pro Tyr
C21H28N4O9 (480.18561980000004)
Asp Ser Tyr Pro
C21H28N4O9 (480.18561980000004)
Asp Tyr Pro Ser
C21H28N4O9 (480.18561980000004)
Asp Tyr Ser Pro
C21H28N4O9 (480.18561980000004)
Glu Ala Asp Phe
C21H28N4O9 (480.18561980000004)
Glu Ala Phe Asp
C21H28N4O9 (480.18561980000004)
Glu Asp Ala Phe
C21H28N4O9 (480.18561980000004)
Glu Asp Phe Ala
C21H28N4O9 (480.18561980000004)
Glu Glu Phe Gly
C21H28N4O9 (480.18561980000004)
Glu Glu Gly Phe
C21H28N4O9 (480.18561980000004)
Glu Phe Ala Asp
C21H28N4O9 (480.18561980000004)
Glu Phe Asp Ala
C21H28N4O9 (480.18561980000004)
Glu Phe Glu Gly
C21H28N4O9 (480.18561980000004)
Glu Phe Gly Glu
C21H28N4O9 (480.18561980000004)
Glu Gly Glu Phe
C21H28N4O9 (480.18561980000004)
Glu Gly Phe Glu
C21H28N4O9 (480.18561980000004)
Glu Met Thr Thr
C18H32N4O9S (480.18899020000003)
Glu Thr Met Thr
C18H32N4O9S (480.18899020000003)
Glu Thr Thr Met
C18H32N4O9S (480.18899020000003)
Phe Ala Asp Glu
C21H28N4O9 (480.18561980000004)
Phe Ala Glu Asp
C21H28N4O9 (480.18561980000004)
Phe Asp Glu Ala
C21H28N4O9 (480.18561980000004)
Phe Glu Ala Asp
C21H28N4O9 (480.18561980000004)
Phe Glu Asp Ala
C21H28N4O9 (480.18561980000004)
Phe Glu Glu Gly
C21H28N4O9 (480.18561980000004)
Phe Glu Gly Glu
C21H28N4O9 (480.18561980000004)
Phe Gly Glu Glu
C21H28N4O9 (480.18561980000004)
Gly Glu Glu Phe
C21H28N4O9 (480.18561980000004)
Gly Glu Phe Glu
C21H28N4O9 (480.18561980000004)
Gly Phe Glu Glu
C21H28N4O9 (480.18561980000004)
Gly His His Met
C19H28N8O5S (480.19032780000003)
Gly His Met His
C19H28N8O5S (480.19032780000003)
Gly Met His His
C19H28N8O5S (480.19032780000003)
His Gly His Met
C19H28N8O5S (480.19032780000003)
His Gly Met His
C19H28N8O5S (480.19032780000003)
His His Gly Met
C19H28N8O5S (480.19032780000003)
His His Met Gly
C19H28N8O5S (480.19032780000003)
His Met Gly His
C19H28N8O5S (480.19032780000003)
His Met His Gly
C19H28N8O5S (480.19032780000003)
Lys Cys Cys Gln
Lys Cys Gln Cys
Lys Gln Cys Cys
Met Glu Thr Thr
C18H32N4O9S (480.18899020000003)
Met Gly His His
C19H28N8O5S (480.19032780000003)
Met His Gly His
C19H28N8O5S (480.19032780000003)
Met His His Gly
C19H28N8O5S (480.19032780000003)
Met Thr Glu Thr
C18H32N4O9S (480.18899020000003)
Met Thr Thr Glu
C18H32N4O9S (480.18899020000003)
Pro Asp Ser Tyr
C21H28N4O9 (480.18561980000004)
Pro Asp Tyr Ser
C21H28N4O9 (480.18561980000004)
Pro Ser Asp Tyr
C21H28N4O9 (480.18561980000004)
Pro Ser Tyr Asp
C21H28N4O9 (480.18561980000004)
Pro Tyr Asp Ser
C21H28N4O9 (480.18561980000004)
Pro Tyr Ser Asp
C21H28N4O9 (480.18561980000004)
Gln Cys Cys Lys
Gln Cys Lys Cys
Gln Lys Cys Cys
Ser Asp Pro Tyr
C21H28N4O9 (480.18561980000004)
Ser Asp Tyr Pro
C21H28N4O9 (480.18561980000004)
Ser Pro Asp Tyr
C21H28N4O9 (480.18561980000004)
Ser Pro Tyr Asp
C21H28N4O9 (480.18561980000004)
Ser Tyr Asp Pro
C21H28N4O9 (480.18561980000004)
Ser Tyr Pro Asp
C21H28N4O9 (480.18561980000004)
Thr Glu Met Thr
C18H32N4O9S (480.18899020000003)
Thr Glu Thr Met
C18H32N4O9S (480.18899020000003)
Thr Met Glu Thr
C18H32N4O9S (480.18899020000003)
Thr Met Thr Glu
C18H32N4O9S (480.18899020000003)
Thr Thr Glu Met
C18H32N4O9S (480.18899020000003)
Thr Thr Met Glu
C18H32N4O9S (480.18899020000003)
Tyr Asp Pro Ser
C21H28N4O9 (480.18561980000004)
Tyr Asp Ser Pro
C21H28N4O9 (480.18561980000004)
Tyr Pro Asp Ser
C21H28N4O9 (480.18561980000004)
Tyr Pro Ser Asp
C21H28N4O9 (480.18561980000004)
Tyr Ser Asp Pro
C21H28N4O9 (480.18561980000004)
Tyr Ser Pro Asp
C21H28N4O9 (480.18561980000004)
2-(4-Chloro-3-(3-(1-hydroxycycloheptyl)propanoyl)phenyl)-4-((2R)-2-hydroxy-3-methoxy-propyl)-1,2,4-triazine-3,5-dione
CE-224535 is a selective P2X7 receptor antagonist.
1,2,3-Propanetricarboxylic acid, 2-[(trimethylsilyl)oxy]-, tris(trimethylsilyl) ester
C18H40O7Si4 (480.18510100000003)
[9-Chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-1-yl] propanoate
C25H33ClO7 (480.19146980000005)
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
C18H32N4O9S (480.18899020000003)
7-[(2-acetylsulfanyl-3-phenylpropanoyl)amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid
C26H28N2O5S (480.17188380000005)
N,N,N-tris(3-pyridylmethyl)benzene-1,3,5-tricarboxamide
C27H24N6O3 (480.19097939999995)
6-amino-1,3-diphenyl-4-(3,4,5-trimethoxyphenyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile
4-[4-Oxo-2-[[2-oxo-2-[(phenylmethyl)amino]ethyl]thio]-3-quinazolinyl]-1-piperidinecarboxylic acid ethyl ester
C25H28N4O4S (480.18311680000005)
N,N,N-tris(4-pyridylmethyl)benzene-1,3,5-tricarboxamide
C27H24N6O3 (480.19097939999995)
7-[4-[4-(2,5-dimethylphenyl)-1-piperazinyl]-4-oxobutyl]-6-sulfanylidene-5H-[1,3]dioxolo[4,5-g]quinazolin-8-one
C25H28N4O4S (480.18311680000005)
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methylanilino)-N-(2-furanylmethyl)-2-(3-pyridinyl)acetamide
C27H24N6O3 (480.19097939999995)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propyl-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H28N4O4S (480.18311680000005)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propyl-N-(2-thiazolyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H28N4O4S (480.18311680000005)
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
(20R)-5alpha-pregnane-3,20-diyl bis(hydrogen sulfate)
(2S,3R,4S)-3-ethenyl-4-[(E)-2-[1-(2-hydroxyethyl)pyridin-1-ium-3-yl]ethenyl]-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
Pregnane-3,20-diol 3,20-disulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(11r,13r)-3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl (2z)-2-methylbut-2-enoate
n-[(2s,3r,4r,6r)-3,16-dihydroxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]ethanimidic acid
(4s,5r,6r)-18-hydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one
(2s)-3-hydroxy-1-{4-methoxy-9h-pyrido[3,4-b]indol-1-yl}-2-({4-methoxy-9h-pyrido[3,4-b]indol-1-yl}methyl)propan-1-one
[(2r,3s,4s)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl 4-hydroxybenzoate
3-hydroxy-2,5-dimethylphenyl 4-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-2-hydroxy-3,5,6-trimethylbenzoate
4-({4'-hydroxy-3-[2-(4-hydroxyphenyl)ethynyl]-4-methyl-[1,1'-biphenyl]-2-yl}(phenyl)methylidene)cyclohexa-2,5-dien-1-one
(2r,3s,4s,5r)-1,6-bis(acetyloxy)-3,4-dihydroxy-5-[(2-isocyano-3-methylbut-2-enoyl)oxy]hexan-2-yl 2-isocyano-3-methylbut-2-enoate
n-{3,16-dihydroxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl}ethanimidic acid
methyl (1s,4ar,6s,7r,7as)-4a,7-dihydroxy-6-[(2s)-2-hydroxypropoxy]-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
[2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl 4-hydroxybenzoate
3-(2-hydroxy-6-methylphenyl)-7-methyl-6,8-dioxoisochromen-7-yl 3-(acetyloxy)-2,4-dimethylhex-4-enoate
(2r,4r,5r,6s)-18-hydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one
[3-(13-methyltetradecyl)-5-(sulfooxy)phenyl]oxidanesulfonic acid
3-hydroxy-1-{4-methoxy-9h-pyrido[3,4-b]indol-1-yl}-2-({4-methoxy-9h-pyrido[3,4-b]indol-1-yl}methyl)propan-1-one
3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl 2-methylbut-2-enoate
(3r)-4-hydroxy-1,3-bis({4-methoxy-9h-pyrido[3,4-b]indol-1-yl})butan-1-one
3-hydroxy-1-{4-methoxy-9h-pyrido[3,4-b]indol-1-yl}-2-({4-methoxy-9h-pyrido[3,4-b]indol-8-yl}methyl)propan-1-one
n-[(2s,3r,4s)-3,16-dihydroxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]ethanimidic acid
[3-(11-methyltetradecyl)-5-(sulfooxy)phenyl]oxidanesulfonic acid
(2s,4s,5r,6r)-18-hydroxy-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaen-16-one
3-hydroxy-2,4,5-trimethylphenyl 3-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-6-hydroxy-2,4-dimethylbenzoate
(3r,10as)-10a-{[(1s,3s,6s)-3-chloro-6-hydroxy-2,2,6-trimethylcyclohexyl]methyl}-3,6,8-trihydroxy-2,2-dimethyl-3h,4h,4ah-naphtho[2,3-b]pyran-5,10-dione
C25H33ClO7 (480.19146980000005)